复杂血管腔内主动脉修复术后亚临床围术期心肌损伤与中期死亡率增加相关:一项回顾性研究
该回顾性研究分析了2012至2022年荷兰三级医院187例择期复杂血管腔内动脉瘤修复(cEVAR)患者,围术期高敏肌钙蛋白T(hsTnT)差值≥14 ng/L定义为围术期心肌损伤(PMI)。41例(21.9%)发生PMI,PMI与4年死亡率独立相关(校正HR 2.37,95%CI 1.21-4.67;术前肌钙蛋白升高和较长手术时间与PMI风险独立相关。
要点
- cEVAR术后约21.9%患者发生无症状PMI,与4年死亡率增加独立相关。
- 术前hsTnT升高和手术时间较长是PMI的独立危险因素。
- 建议对cEVAR患者考虑常规围术期hsTnT监测以识别高危患者。
核心结论
- 无症状PMI在cEVAR术后相对常见,并与中期生存受损相关。
- 鉴于PMI患者心血管合并症高发,前瞻性随访研究应关注常规围术期hsTnT监测识别可从强化心脏护理中获益的高危患者。
研究设计与样本
- 回顾性分析2012至2022年荷兰三级医院所有择期cEVAR患者。
- 共纳入187例患者,中位随访56个月。
- PMI定义为术前与术后hsTnT差值≥14 ng/L且无心肌梗死临床特征。
- 研究遵循STROBE指南。
主要发现
- 41例(21.9%)发生PMI。
关键数值与推荐
- PMI定义:术前与术后hsTnT差值≥14 ng/L且无心肌梗死临床特征。
- 主要目标:cEVAR术后PMI发生率及其与4年死亡率的关联。
临床怎么用
- 对cEVAR患者可考虑常规围术期hsTnT监测以识别无症状PMI。
- 识别PMI高危患者(术前肌钙蛋白升高、较长手术时间)并强化心脏护理。
局限性
- 回顾性研究设计。
- 单中心研究。
- 缺乏常规围术期肌钙蛋白监测数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Peri-operative myocardial injury (PMI), defined by an asymptomatic increase in troponin levels, has been recognised as a prognostic marker for impaired survival following non-cardiac surgery, with therapy for improvement potentially available. Patients undergoing complex endovascular aneurysm repair (cEVAR) may be at particular risk of PMI owing to their cardiovascular burden. However, due to lack of routine peri-operative troponin monitoring, the incidence proportion and association between PMI and long term mortality following cEVAR remains unclear, with no possibility of applying improvement strategies. METHODS: Pre-operative and consecutive post-operative high sensitivity troponin T (hsTnT) levels were retrospectively analysed from all patients who underwent elective cEVAR in a Dutch tertiary hospital between 2012 and 2022. PMI was defined as the difference between pre- and post-operative troponin concentrations (ΔhsTnT) of ≥ 14 ng/L in the absence of clinical features of myocardial infarction. Primary objectives were the incidence proportion of PMI following cEVAR and its association with 4 year mortality. The study adhered to the STROBE guidelines. RESULTS: A total of 187 patients were included. The median follow up was 56 months. Forty-one patients (21.9%) developed PMI. Coronary artery disease was more prevalent (65.9% vs. 41.8%; p = .018) and American Society of Anesthesiologists (ASA) scores were higher (ASA 4, 13.1% vs. 7.8%; p = .023) in patients with PMI. PMI was independently associated with an increased 4 year mortality rate (adjusted hazard ratio [HR] 2.37, 95% confidence interval [CI] 1.21 - 4.67; p = .013). Pre-operative elevated troponin levels (adjusted HR 2.91, 95% CI 1.41 - 6.33; p = .005) and longer operation time (adjusted HR 1.01, 95% CI 1.00 - 1.01; p = .002) were independently associated with an increased risk of PMI. CONCLUSION: Asymptomatic PMI is relatively common following cEVAR and is associated with impaired midterm survival. Given the high prevalence of cardiovascular comorbidities in patients with PMI, prospective follow up studies should focus on the potential of routine peri-operative hsTnT monitoring for identifying high risk patients who could potentially benefit from enhanced cardiac care.
引用
- Vecht DE, Vanmaele A, Rastogi V, et al. Subclinical Peri-operative Myocardial Injury following Complex Endovascular Aortic Repair is Associated with Increased Midterm Mortality: A Retrospective Study. Eur J Vasc Endovasc Surg. 2026. PMID: 41942061. doi:10.1016/j.ejvs.2026.03.056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。